An EMBO journal has issued a correction for a well-cited 2012 review co-authored by a cancer researcher under investigation.
Carlo Croce, the last author on the review, has been beleaguered by misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times), and his university has recently re-opened an investigation into his work.
By our count, Croce — based at The Ohio State University — has logged six retractions, along with multiple expressions of concerns and corrections. The latest correction, in EMBO Molecular Medicine, notes the review lifted passages from multiple publications — and was in turn reused in later papers, as well.
Here’s the notice:
Continue reading OSU researcher under investigation corrects paper cited 500 times
After a paper is published, how long should a journal consider allegations of misconduct? For one journal, that answer is: Six years.
Science Translational Medicine has retracted a paper by researchers based in Switzerland, after an investigation concluded two figures had been manipulated.

A neurochemistry journal has retracted a paper from a group in China over a duplicated image.
On April 27, the Journal of Biological Chemistry (JBC) retracted nine papers by a researcher based in Israel, including some dating back to 2000.